Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05551195 · ClinicalTrials.gov registry record · NA
[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]
A NA study, sponsored by Woebot Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05551195 is a NA study that was terminated before completion, run by Woebot Health. The registered enrollment target is 7 participants.
The verdict
NCT05551195, a NA study, was terminated before completion, sponsored by Woebot Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of two digital therapeutics, WB001 and ED001, on depressive symptoms among women diagnosed with postpartum depression.
Interventions
- DEVICE WB001
- DEVICE ED001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2023-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05551195
The ClinicalTrials.gov registry entry for NCT05551195 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WB001 is the first listed.
NCT05551195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05551195 about?
NCT05551195 is a clinical study titled "[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]". This study evaluates the efficacy of two digital therapeutics, WB001 and ED001, on depressive symptoms among women diagnosed with postpartum depression.
What is the current status of trial NCT05551195?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2022-11-16. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT05551195?
The interventions under investigation include: WB001 (DEVICE), ED001 (DEVICE).
Who is sponsoring clinical trial NCT05551195?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.